E

ENGN

ENGN

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
ENGN Live QuoteDaily Close
$150.00
+$149.00(+14900.00%)1M
Day Range$147.75 – $152.25
Open$150.00
Previous Close$150.00
Volume15.4M
Key Financials & Valuation
Fundamental balance sheet & market metrics
General
Market Cap$50.00B
P/E Ratio (TTM)24.5
Forward P/E21.0
EPS (TTM)$4.12
Price to Book5.2
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryEquities
52-Week RangeCurrent: $150.00 (50%)
Low: $112.50High: $187.50
Wall Street Consensus
Buy
Analyst Rating
4.1/ 5.0
Target Price
$172.50+15.0% upside

Insider Buys

2

$5.01M

Insider Sales

0

$0

Total Volume

$5.01M

2 transactions

Net Activity

+$5.01M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
85CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
F
1

Forbion Growth Opportunities Fund I Cooperatief U.A.

10%

1 buys0 sells

$5.00M total

G
2

Grossman William

Interim Chief Medical Officer

1 buys0 sells

$10K total

Trading History
ENGN insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 22, 2026

1 months ago

Grossman William

Interim Chief Medical Officer

C-Level
Buy5.1K$1.97$10K

Oct 30, 2024

25 months ago

Forbion Growth Opportunities Fund I Cooperatief U.A.

10%

10% Owner
Buy561.8K$8.90$5.00M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ENGN Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

ENGN has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ENGN

Over the last 90 days, corporate insiders at ENGN (ENGN) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $5.01M.

The net insider activity for ENGN shows a net buying bias of $5.01M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Forbion Growth Opportunities Fund I Cooperatief U.A. (10%), who traded 561.8K shares valued at $5.00M on Oct 30, 2024.

Live Market News & Developments
Aggregated real-time headlines for ENGN (ENGN)
6 updates

EnGene Therapeutics (ENGN) Stock Gets Fair Value Boost After Analyst Views On LEGEND Data

Yahoo Finance5d ago

StockWatch: enGene Shares Crater on Declines in Complete Response Rates to Bladder Cancer Therapy

Genetic Engineering and Biotechnology News193d ago

ENGN: Detalimogene advances toward a 2027 approval, with a surfactant-cohort update planned for midyear

TradingView3d ago

enGene rises after mid-stage trial data for bladder cancer therapy; Piper upgrades

Seeking Alpha7d ago

ENGN - enGene Therapeutics Inc Stock Price and Quote

Finviz175d ago

Warrants at $0.0001 a share factor into a fund's reported enGene Therapeutics (ENGN) stake.

Stock Titan3d ago

FAQs About ENGN Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ENGN.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ENGN is currently 85/100, which reflects a strong accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ENGN is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.